GlassScriptPhysician profile
Christopher W Wagener
NPI 1063406064
$5,776.90
in general payments reported to CMS, 2019-2025
15 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $852 · 2020: $4,235 · 2022: $44.56 · 2023: $156 · 2024: $278 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $645.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $644.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,259.94 | 2020-2022 | |
| Medtronic USA, INC. | $776.37 | 2019 | |
| Abbvie INC. | $164.34 | 2019-2025 | |
| Medtronic, INC. | $122.11 | 2023-2025 | Interstim, V-Loc 180 |
| Axonics, INC. | $113.60 | 2023-2024 | Axonics |
| Boston Scientific Corporation | $69.45 | 2025 | Upsylon |
| Daiichi Sankyo INC. | $52.06 | 2024 | Injectafer |
| Pfizer INC. | $39.56 | 2024-2025 | |
| Astellas Pharma US INC | $39.51 | 2024 | Veozah |
| Sumitomo Pharma America, INC. | $36.72 | 2023-2025 | Myfembree |
| Minerva Surgical, INC | $34.41 | 2025 | |
| Smith+Nephew, INC. | $22.68 | 2025 | Pico 14 |
| Organon LLC | $16.74 | 2024 | |
| Merck Sharp & Dohme LLC | $16.41 | 2023 | Gardasil 9 |
| Exeltis, USA INC. | $13.00 | 2023 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Wagener listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.